1. Home
  2. HUN vs RXRX Comparison

HUN vs RXRX Comparison

Compare HUN & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUN
  • RXRX
  • Stock Information
  • Founded
  • HUN 1970
  • RXRX 2013
  • Country
  • HUN United States
  • RXRX United States
  • Employees
  • HUN N/A
  • RXRX N/A
  • Industry
  • HUN Major Chemicals
  • RXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUN Industrials
  • RXRX Health Care
  • Exchange
  • HUN Nasdaq
  • RXRX Nasdaq
  • Market Cap
  • HUN 1.7B
  • RXRX 2.0B
  • IPO Year
  • HUN 2005
  • RXRX 2021
  • Fundamental
  • Price
  • HUN $9.20
  • RXRX $5.68
  • Analyst Decision
  • HUN Hold
  • RXRX Buy
  • Analyst Count
  • HUN 9
  • RXRX 5
  • Target Price
  • HUN $13.17
  • RXRX $7.00
  • AVG Volume (30 Days)
  • HUN 5.1M
  • RXRX 32.2M
  • Earning Date
  • HUN 07-31-2025
  • RXRX 08-05-2025
  • Dividend Yield
  • HUN 10.86%
  • RXRX N/A
  • EPS Growth
  • HUN N/A
  • RXRX N/A
  • EPS
  • HUN N/A
  • RXRX N/A
  • Revenue
  • HUN $5,860,000,000.00
  • RXRX $59,790,000.00
  • Revenue This Year
  • HUN N/A
  • RXRX $19.96
  • Revenue Next Year
  • HUN $4.95
  • RXRX $61.39
  • P/E Ratio
  • HUN N/A
  • RXRX N/A
  • Revenue Growth
  • HUN N/A
  • RXRX 29.32
  • 52 Week Low
  • HUN $9.03
  • RXRX $3.79
  • 52 Week High
  • HUN $25.12
  • RXRX $12.36
  • Technical
  • Relative Strength Index (RSI)
  • HUN 30.98
  • RXRX 49.56
  • Support Level
  • HUN $10.79
  • RXRX $5.70
  • Resistance Level
  • HUN $12.33
  • RXRX $6.69
  • Average True Range (ATR)
  • HUN 0.52
  • RXRX 0.50
  • MACD
  • HUN -0.22
  • RXRX -0.05
  • Stochastic Oscillator
  • HUN 5.30
  • RXRX 27.23

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Share on Social Networks: